Piyasa Kapitalizasyonu Değişiklik Tarih
AbbVie USD 403.83B 5.2B 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
J&J USD 500.24B 67.44B 2025-12
MacroGenics USD 192M 90M 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Xencor USD 1.09B 256M 2025-12